Cell-based therapy for peripheral arterial diseases
- Authors: Shoykhet, Y.N1, Khorev NG1
-
Affiliations:
- SEI of HPE «Altay State Medical University» of the Federal Agency of Public Health and Social Development,Barnaul
- Issue: Vol 6, No 3 (2011)
- Pages: 15-23
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/121544
- DOI: https://doi.org/10.23868/gc121544
- ID: 121544
Cite item
Open Access
Access granted
Subscription or Fee Access
Abstract
The number of peripheral artery disease remains in the
world. Search for new methods of treatment is to improve
the condition of the distal blood stream, reduce peripheral
resistance and stimulating capillary network. One possible
solution to this problem is to use cellular technologies stimulate
angiogenesis. A new promising treatments is autologous cell
therapy using BMMNC or PBMNC. This overview focuses on
the exploration of autologous cell therapy in treating diseases
of the peripheral arteries.
world. Search for new methods of treatment is to improve
the condition of the distal blood stream, reduce peripheral
resistance and stimulating capillary network. One possible
solution to this problem is to use cellular technologies stimulate
angiogenesis. A new promising treatments is autologous cell
therapy using BMMNC or PBMNC. This overview focuses on
the exploration of autologous cell therapy in treating diseases
of the peripheral arteries.
About the authors
Ya N Shoykhet,
SEI of HPE «Altay State Medical University» of the Federal Agency of Public Health and Social Development,BarnaulSEI of HPE «Altay State Medical University» of the Federal Agency of Public Health and Social Development,Barnaul
N G Khorev
SEI of HPE «Altay State Medical University» of the Federal Agency of Public Health and Social Development,BarnaulSEI of HPE «Altay State Medical University» of the Federal Agency of Public Health and Social Development,Barnaul
References
- Criqui M.H., Fronec A., Barrett-Connor E. et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71(3): 510-51.
- Fowkes F.G., Houstley E., Cawood E.H. et al. Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int. J. Epidemiol. 1991; 20(2): 384-92.
- Kannel W.B., Skinner Jr.J., Schwartz M.J. Intermittent claudication. Incidence in the Framingham study. Circulation 1970; 41(5): 875-83
- Adam D.J., Beard J.D., Cleveland T. et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre randomised controlled trial. Lancet 2005; 366: 1925-34.
- Buschmann I., Schaper W. The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 2000; 190: 338-42.
- Heilmann C., Beyersdorf F., Lutter G. Collateral growth: cells arrive at the construction site. Cardiovasc. Surg. 2002; 10: 570-8.
- Shintani S., Murohara T., Ikeda H. et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776-9.
- Takahashi T., Kalka C., Masuda H. et al. Ischemia- and cytokineinduced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999; 5: 434-8.
- Tateishi-Yuyama E., Matsubara H., Murohara T. et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360: 427-35.
- Strauer B.E., Brehm M., Zeus T. et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002; 106: 1913-8.
- Rutherford R.B., Baker J.D., Ernst C. et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J. Vasc. Surg. 1997; 26: 517-38.
- Asahara T., Murohara T., Sullivan A. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
- Timmermans F., Plum J., Yoder M.C. et al. Endothelial progenitor cells: identity defined? J. Cell Mol. Med. 2009; 13: 87-102.
- Timmermans F., Van H.F., De S.M. et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler. Thromb. Vasc. Biol. 2007; 27: 1572-9.
- Purhonen S., Palm J., Rossi D. et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. PNAS USA 2008; 105: 6620-5.
- Canizo M.C., Lozano F., Gonzalez-Porras J.R. et al. Peripheral endothelial progenitor cells (CD133+) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up. Cytotherapy 2007; 9: 99-102.
- Kudo F.A., Nishibe T., Nishibe M. et al. Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. Int. Angiol. 2003; 22: 344-8.
- Iohara K., Zheng L., Wake H. et al. A novel stem cell source for vasculogenesis in ischemia: subfraction of side population cells from dental pulp. Stem Cells 2008; 26: 2408-18.
- Sanz-Ruiz R., Fernandez-Santos E., Dominguez-Munoa M. et al. Early translation of adipose-derived cell therapy for cardiovascular disease. Cell Transpl. 2009; 18: 245-54.
- Murphy M.P., Wang H., Patel A.N. et al. Allogeneic endometrial regenerative cells: an «Off the shelf solution» for critical limb ischemia? J. Transl. Med. 2008; 6: 45.
- Huang Y.C., Yang Z.M., Chen X.H. et al. Isolation of mesenchymal stem Cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev. Rep. 2009: 5(3): 247-55.
- Finney M.R., Greco N.J., Haynesworth S.E. et al. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Biol. Blood Marrow Transpl. 2006; 12: 585-93.
- Boyum A. Separation of lymphocytes, lymphocyte subgroups and monocytes: a review. Lymphology 1977; 10: 71-6.
- Boyum A. Separation of lymphocytes, granulocytes, and monocytes from human blood using iodinated density gradient media. Methods Enzymol. 1984; 108: 88-102.
- Boyum A., Lovhaug D., Tresland L. et al. Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality. Scand. J. Immunol. 1991; 34: 697-712.
Supplementary files
